Oncotarget

Corrections:

Correction: Melatonin attenuated the brain damage and cognitive impairment partially through MT2 melatonin receptor in mice with chronic cerebral hypoperfusion

PDF  |  How to cite

Oncotarget. 2020; 11:3558-3558. https://doi.org/10.18632/oncotarget.27754

Metrics: PDF 377 views  |   ?  

Tzu-Hsien Tsai1,2, Cheng-Jei Lin1, Sarah Chua1, Sheng-Ying Chung1, Cheng-Hsu Yang1, Meng-Shen Tong1 and Chi-Ling Hang1

1 Division of Cardiology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan
2 Center for Translational Research in Biomedical Sciences, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan

Published: September 22, 2020

This article has been corrected: The co-first author, Cheng-Jei Lin, has been removed as an equal contributor for this study as compared to the first author.

Original article: Oncotarget. 2017; 8:74320–74330. DOI: https://doi.org/10.18632/oncotarget.20382.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 27754